Author:
Castle David,Bosanac Peter
Abstract
SummaryDepressive symptoms commonly occur in schizophrenia and have a significant impact on the distress and burden of the illness. Yet they are often overlooked, inadequately characterised by current classification systems and not consistently integrated into treatment. We discuss nosology, practical and clinical implications of symptom differentiation, and the role of causal and confounding factors, including iatrogenic, as targets for therapeutic intervention. The evidence base of psychosocial and psychotropic management is reviewed, with recommendations for the treatment of established syndromal depression in people with schizophrenia.
Publisher
Cambridge University Press (CUP)
Subject
Psychiatry and Mental health
Reference74 articles.
1. Sertraline in the treatment of depressive symptoms in stable, chronic schizophrenia: A placebo controlled trial
2. Atypical antipsychotics for people with both schizophrenia and depression;Furtado;Cochrane Database of Systematic Reviews,2008
3. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences
4. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study;Cutler;Journal of Clinical Psychiatry,2009
5. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder;Papakostas;Journal of Clinical Psychiatry,2005